These drugs mimic GLP-1 to promote weight loss and improve metabolic health
The FDA recently approved Bysanti (milsaperidone) for: Schizophrenia (adults) Acute manic or mixed episodes in Bipolar I Disorder (adults) One of the most important clinical considerations with this medication
However, advancements in laser technology have led to the development of lasers that are safer and more effective for darker skin tones, reducing the risk of this side effect
Eschbach J, Von Einem B, Muller K, Bayer H, Scheffold A, Morrison BE, Rudolph KL, Thal DR, Witting A, Weydt P et al (2014) Mutual exacerbation of peroxisome proliferator-activated receptor coactivator 1 deregulation and -synuclein oligomerization
Alcohol use : Synergistic trigger
Never freeze tirzepatide, as crystallization damages the medication and makes it unsafe to inject